Sofosbuvir 400 mg

Sofosbuvir 400 mg
Product Description

- Presentation: Plastic bottles with 28 coated tablets.  

- Indication (Brazil Prescription Medicines): indicated for the treatment of chronic hepatitis C Virus infection in adult patients, in combination with other antiviral agents.

- Recommended Dosage: 1 tablet once a day  

- Stability Study: 
Zone IV B
(30ºC / 75% RH) 

- Patent Year: 2018 

- Status in Brazil: Approved  

Our finished dosage products are produced, delivered and distributed in Brazil through the Brazilian state-owned laboratories. Blanver fully respects the patents’ expiration dates in all countries.

Read more Show less

Blanver Farmoquimica Ltda.

  • BR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Other
View company profile
Categories
more categories Show less

Blanver Farmoquimica Ltda.

  • BR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Other
View company profile

More Products from Blanver Farmoquimica Ltda. (7)

  • CILOSTAZOL

    Product CILOSTAZOL

    Antiplatelet Agents and vasodilator, Hematologic; Phosphodiesterase 3 (PDE3) Inhibitors; Phospholipase A2 Inhibitors; Antithrombotic.
  • Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

    Product Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

    - Presentation: Plastic bottles with 30 coated tablets.  

    - Indication (Brazil Prescription Medicines): 
    1) For PrEP® (pre-exposure prophylaxis), it can help reduce the risk of getting HIV-1 through sex, when taken every day and used together with safer sex practices.
    ...
  • Raloxifene Hydrochloride 60 mg

    Product Raloxifene Hydrochloride 60 mg

    - Presentation: Blisters containing 28 film-coated tablets  

    - Indication (Brazil Prescription Medicines): 
    1) For the prevention and treatment of osteoporosis;
    2) To reduce the risk of breast cancer in postmenopausal womem with osteoporosis.

    -...
  • Tenofovir Disoproxil Fumarate

    Product Tenofovir Disoproxil Fumarate

    API - Active Pharmaceutical Ingredient

    - Therapeutic Area: HIV infection and Chronic Hepatitis B
    - Status: DMF (Drug Master File Ready) 

    Blanver fully respects the patents’ expiration dates in all countries
  • Tenofovir Disoproxil Fumarate 300 mg

    Product Tenofovir Disoproxil Fumarate 300 mg

    - Presentation: Package containing 60 plastic bottles with 30 coated tablets.

    - Indication (Brazil Prescription Medicines): First line medication indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults and chronic Hepatitis B.
    ...
  • Tenofovir Disoproxil Fumarate 300 mg + Lamivudine 300 mg

    Product Tenofovir Disoproxil Fumarate 300 mg + Lamivudine 300 mg

    - Presentation: Plastic bottles with 30 coated tablets.

     - Indication (Brazil Prescription Medicines): Used with other HIV-1 medicines to treat HIV-1 infection. Its use can promote greater adherence to the treatment and also reduce the cost and number of pills taken daily.
    ...
  • Lithium Carbonate

    Product Lithium Carbonate

    API - Active Pharmaceutical Ingredient

    - Therapeutic Area: Bipolar Disorder and Major Depressive Disorder as adjunctive
    - Status: DMF (Drug Master File) ready

    Blanver fully respects the patents’ expiration dates in all countries*

Blanver Farmoquimica Ltda. resources (1)